Circulating tumor DNA analysis: potential to revise adjuvant therapy for stage II colorectal cancer

Signal Transduct Target Ther. 2022 Sep 5;7(1):308. doi: 10.1038/s41392-022-01164-y.

Ning Zhu^#^{1

2}, Hanguang Hu^#¹, Ying Yuan^{3

4

5}

¹ Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
² Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
³ Department of Medical Oncology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. yuanying1999@zju.edu.cn.
⁴ Cancer Institute, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. yuanying1999@zju.edu.cn.
⁵ Cancer Center, Zhejiang University, Hangzhou, Zhejiang, China. yuanying1999@zju.edu.cn.

^# Contributed equally.

No abstract available

Publication types